Verition Fund Management LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 219 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2023$208,351
-78.3%
34,100
+64.4%
0.00%
-62.5%
Q4 2020$962,000
-18.1%
20,742
-41.8%
0.01%
-65.2%
Q3 2020$1,174,000
+254.7%
35,656
+195.8%
0.02%
+109.1%
Q2 2020$331,00012,0550.01%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders